For St. Paul residents, the nearest obesity specialist may be a long drive away. Wegovy® is the FDA-approved Injectable pen Semaglutide product by Novo Nordisk, approved since 2021 for Chronic weight management. Weight Method offers a separate program: licensed Minnesota providers evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program starts at $199/month, including the provider evaluation, the medication, ongoing care, and shipping to St. Paul.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · St. Paul is already seeing results
GLP-1 weight-loss treatment available to eligible patients in St. Paul, MN. Weight Method offers compounded semaglutide, prescribed by licensed providers, from $199/month with virtual consultations and direct-to-door shipping.
For many people in St. Paul, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Semaglutide addresses hormonal drivers involved in body weight regulation. Wegovy® is the FDA-approved Injectable pen Semaglutide product by Novo Nordisk, approved in 2021 for Chronic weight management. Weight Method offers a separate telehealth program: licensed providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The program is priced at $199/month, including the evaluation, the medication, ongoing care, and home delivery to St. Paul.
Urban residents in St. Paul are often surrounded by healthcare options yet still struggle to access GLP-1 treatment. Primary care physicians may not specialize in GLP-1 prescribing, and specialist clinics charge $500+ per visit. Weight Method's all-inclusive compounded Semaglutide program — consultation, medication, and ongoing support at $199/month — is built for the urban patient who values quality and efficiency. Compounded Semaglutide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Minnesota and start Wegovy from $199/month.
Get Started NowFree consultation. No commitment.